| Financial Year |
March 31 2022 |
| Monetary Funds |
12,914,925.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
9,158,933.48 |
| Advances to Suppliers |
17,012,041.77 |
| Other Receivables |
52,176,399.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
46,156,893.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,870,736.28 |
| Total Current Assets |
176,289,929.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,167,014,672.17 |
| Under-construction Projects |
4,262,173.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
43,340,163.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
845,869.47 |
| Deferred Income Tax Assets |
8,380,812.56 |
| Other Non-Current Assets |
4,939,080.25 |
| Sub-Total of Non-Current Assets |
1,248,464,267.98 |
| Total Assets |
1,424,754,197.79 |
| Short-Term Loans |
570,403,688.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
221,446,682.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,938,665.79 |
| Taxes Payable |
12,808,414.46 |
| Interest Payable |
150,266,676.00 |
| Dividend Payable |
-- |
| Other payables |
194,049,401.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,101,919.36 |
| Sub-Total of Current Liabilities |
1,073,331,791.42 |
| Long-term Loans |
3,951,018.26 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,500,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
179,853,008.31 |
| Deferred Income Tax Liabilities |
791,480.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
219,267,175.83 |
| Total Liabilities |
1,292,598,967.25 |
| Paid-In Capital(Or Share Stock) |
1,094,867,797.00 |
| Capital Surplus |
6,318,678.34 |
| Surplus Reserve |
49,575,995.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,018,607,240.03 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
132,155,230.54 |
| Owner's Equity（Stockholder's Equity） |
132,155,230.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,424,754,197.79 |
